![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety Profile of HIV-1 Patients Co-Infected With Hepatitis B or C in the Maraviroc Expanded Access Program
|
|
|
Reported by Jules Levin
EACS Nov 13 2009 Cologne Germany
A Lazzarin1, S Than2, S R Valluri2, G Mukwaya2and A Ayoub3
1San Raffaele Scientific Institute, Milan, Italy; 2Pfizer Inc, New York, NY, USA; 3Pfizer Global R&D, Sandwich, UK
For further information, please contact: Soe Than and Srinivas Rao Valluri, Pfizer Inc, New York, NY.
![image002.gif](../images/112309/112409-7/image002.gif)
![image004.gif](../images/112309/112409-7/image004.gif)
![image006.gif](../images/112309/112409-7/image006.gif)
![image008.gif](../images/112309/112409-7/image008.gif)
![image010.gif](../images/112309/112409-7/image010.gif)
![image012.gif](../images/112309/112409-7/image012.gif)
![image014.gif](../images/112309/112409-7/image014.gif)
RESULTS
![image016.gif](../images/112309/112409-7/image016.gif)
![image018.gif](../images/112309/112409-7/image018.gif)
![image020.gif](../images/112309/112409-7/image020.gif)
![image022.gif](../images/112309/112409-7/image022.gif)
![image024.gif](../images/112309/112409-7/image024.gif)
![image026.gif](../images/112309/112409-7/image026.gif)
References
1. Gulick RM, et al. N Engl J Med2008;359:1429-1441.
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|